2010
  1. Schnute,M.E., O'Brien,P.M., Nahra,J., Morris,M., Howard Roark,W., Hanau,C.E., Ruminski,P.G., Scholten,J.A., Fletcher,T.R., Hamper,B.C., Carroll,J.N., Patt,W.C., Shieh,H.S., Collins,B., Pavlovsky,A.G., Palmquist,K.E., Aston,K.W., Hitchcock,J., Rogers,M.D., McDonald,J., Johnson,A.R., Munie,G.E., Wittwer,A.J., Man,C.F., Settle,S.L., Nemirovskiy,O., Vickery,L.E., Agawal,A., Dyer,R.D. and Sunyer,T.
    Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
    Bioorg Med Chem Lett20, 576-580. PubMed  Europe PubMed DOI  I